Effects of a Telerehabilitation Intervention in the Management of Complications After Breast Cancer Surgery
Recruiting now · Not applicable
Conditions studied: Breast Neoplasms
In brief
The most common complaints after breast surgery are postoperative pain reported in up to 68% of patients, musculoskeletal problems in the shoulder and functional limitations in up to 59% of patients after mastectomy and quadrantectomy, reduction in range of motion ( ROM) in 24-53% and strength deficit. The study aims to verify the effectiveness of a telerehabilitation treatment in terms of prevention of possible complications following breast cancer surgery. Primary objective: to examine whether the group of patients undergoing rehabilitation surgery in the immediate post-operative period shows a reduction in the onset of complications compared to the group of patients who followed standard procedures. Secondary objective: to study any preoperative prognostic factors for the onset of complications, to study the effectiveness of the rehabilitation treatment in terms of reduction of painful symptoms, improvement of joint ROM, muscle strength and perceived quality of life.
Key facts
- Study ID
- NCT06608446
- Run by
- Fondazione Policlinico Universitario Campus Bio-Medico
- People needed
- 155
- Starts
- 2023-05-15
- Expected to finish
- 2026-07-30
- Last updated by the study team
- 2026-04-21
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- diagnosis of breast cancer
- Having undergone quadrantectomy or mastectomy surgery
- Age > 18 years
- Signature of informed consent
You may not qualify if…
- Neurological deficits with sensorimotor impairment of the upper limb
- Cognitive deficits that prevent the completion of questionnaires (MMSE>24)
Where it is running
- Fondazione Policlinico Universitario Campus Bio-Medico — Roma, Roma, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.